Frequently Asked Questions about Nkarta, Inc. (NKTX)

Name: Nkarta, Inc. (NKTX) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Nkarta, Inc. (NKTX) do?

Accepted Answer

Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific p...

Question 2

Is Nkarta, Inc. (NKTX) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of NKTX reveals an Altman Z-Score of -1.37 and a Piotroski F-Score of 1/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if NKTX fits their risk profile.

Question 3

What is the current P/E ratio for NKTX?

Accepted Answer

As of the latest trading session, Nkarta, Inc. (NKTX) has a trailing P/E ratio of -1.56.

Question 4

Who is the CEO of Nkarta, Inc.?

Accepted Answer

The current Chief Executive Officer of Nkarta, Inc. is Paul J. Hastings.

Question 5

What was NKTX's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Nkarta, Inc. reported annual revenues of $0.00B (2025), $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021) respectively.

Question 6

Does NKTX pay a dividend?

Accepted Answer

Nkarta, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does NKTX have?

Accepted Answer

In its latest reporting period, Nkarta, Inc. generated $-0.09B in Free Cash Flow against a total debt load of $0.08B.

Question 8

What is the Price-to-Book (P/B) ratio of Nkarta, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Nkarta, Inc. (NKTX) is currently 0.52.

Question 9

What is the Price-to-Sales (P/S) ratio of NKTX?

Accepted Answer

Based on trailing twelve-month data, Nkarta, Inc. (NKTX) trades at a Price-to-Sales (P/S) ratio of 0.00.

Question 10

What is Nkarta, Inc.'s Return on Equity (ROE)?

Accepted Answer

Nkarta, Inc. (NKTX) has a Return on Equity (ROE) of -30.02%, representing its profitability relative to shareholder equity.

Period	Gross Profit	Op. Income	Net Income	EPS
2025-12	-9.2M	-121.2M	-104.1M	-1.41
2024-12	0	-128.2M	-108.8M	-1.60
2023-12	-5.9M	-131.7M	-117.5M	-2.40
2022-12	0	-119M	-113.8M	-2.61
2021-12	0	-86.4M	-86.1M	-2.62